Tests of Lira in APP/PS1 AD mice show that it crosses the BBB, prevents memory loss and hippocampal deterioration, increases the number of young neurons in the dentate gyrus, and reduces neuronal inflammation, Aβ oligomer and APP levels, and Aβ plaque formation [47,48,49]. This evidence concerns the gene APP and Alzheimer disease.